Hello, I am Ahed Ebrahim
Founder & Chief Executive Officer, HelixKube
Ahed Ebrahim is the Founder and CEO of HelixKube, bringing over 20 years of international expertise in strategic management, large-scale transformation, and corporate governance, across the most critical sectors of the healthcare landscape. Based in the GTA, Ontario, Ahed has built a career focused on delivering measurable business and policy impact by advising C-suite executives and building high-performing teams in highly regulated environments. His executive focus is on translating complex strategy and regulatory requirements into sustainable, compliant operational frameworks.
A unique blend of clinical understanding (holding a Bachelor of Pharmacy) with an MBA from the University of Strathclyde, UK, allows Ahed to drive tangible outcomes where scientific innovation meets complex operational demands.
- Email address support@helixkube.com
- Phone number (800) 817 7607 [Canada]
A Foundation in Big Four Consulting
Ahed’s strategic foundation was built during extensive tenures as a former Big Four consultant at both PwC (PricewaterhouseCoopers) and EY (Ernst & Young), cementing his expertise in driving large-scale global transformations and commercial strategy. His time in these organizations provided rigorous training in applying structure and data-driven methods to ambiguous, high-stakes client challenges across global markets.
- Strategy & Transactions (EY): As a Senior Manager in Transactions Advisory, Ahed directed strategic planning for major integrated projects across the Middle East. This notably included the development of a feasibility study and business plan for the establishment of a Healthcare City & Bio Pharma Cluster that integrated policy, infrastructure, and financial planning on a national scale. This involved complex stakeholder management, economic feasibility studies, and the design of commercial and governance structures necessary for long-term operational viability and investment attraction.
- Global Market Entry (PwC): During his time at PwC, Ahed led market entry strategies for multinational pharmaceutical firms (Pfizer) across the GCC and North Africa. This work was crucial for clients seeking to navigate complex local regulatory environments and establish compliant distribution channels. His focus was on commercial due diligence, performance improvement, and designing transformation roadmaps to accelerate market penetration and achieve critical business objectives across diverse global markets.
Specialized Healthcare and Government Transformation
Ahed is a recognized specialist in the Healthcare and Life Sciences domain, with a proven track record of successful collaboration with both government regulatory bodies and private sector investors and enterprises. His expertise lies in navigating the intersection of public policy, business strategy, large-scale health system financing, and the technical demands of drug manufacturing and distribution.
- Executive Health Policy Advisory: Ahed served as Assistant Vice President for Corporate Affairs and Government Relations at Daman National Insurance Company. In this role, he supported the CEO and Vice President on strategic and operational issues related to the implementation of the National Health Insurance programs on behalf of the government, including overseeing the delivery of critical national insurance schemes.
- Government Leadership: Directed multiple large-scale government transformation initiatives that restructured health system financing, reformed licensing and inspection frameworks, and enhanced emergency preparedness for major regulatory authorities. This work ensured public health systems could operate efficiently, maintain high standards of compliance, and adapt rapidly to dynamic health crises while optimizing taxpayer funds.
- Health Policy & Crisis Response: Advised senior executives and regulators on critical public health initiatives, including the design of Health Emergency & Disaster Management strategies and national medicine stockpiling frameworks. This involved developing resilient supply chain models capable of rapid scale-up, ensuring continuity of essential health services, and advising on policy changes to secure vital medical resources.
- Operational Excellence: Instrumental in driving organizational restructuring and improving operational performance by establishing best practices in operational excellence, quality management and risk frameworks to achieve sustainable enterprise-wide performance improvement (Roche). This includes developing robust Standard Operating Procedures (SOPs), implementing quality management systems, and ensuring compliance with international regulatory standards.
Core Areas of Influence for HelixKube Clients
Ahed provides HelixKube clients with expertise across four critical pillars, helping them achieve clarity, compliance, and competitive advantage:
- Business Development & Transactions: Leading strategic growth initiatives in healthcare investments (Feasibility for a new Generic Manufacturing Plant), managing valuation and transaction advisory projects, and conducting commercial due diligence for pharma and life sciences projects (Valuation of a Biosimilar Insulin Manufacturing Plant) This ensures clients’ M&A decisions are informed by deep sector knowledge, realistic market forecasts, and a clear understanding of integration risks.
- Strategy Implementation: Delivering high-impact projects and leading transformation initiatives across healthcare, life sciences, government, and regulatory sectors for multinational companies. Ahed specializes in converting strategic plans into actionable operational roadmaps, ensuring alignment from the boardroom to the front line.
- Corporate Governance: Designing robust governance strategies, policies, Standard Operating Procedures (SOPs), and delegation of authority frameworks for complex, large-scale organizations. This establishes transparent accountability, mitigates institutional risk, and optimizes organizational decision-making processes.
- Performance Improvement: Driving organizational restructuring, improving operational performance, ensuring operational excellence and regulatory and operational compliance (AstraZeneca), and leveraging quality management and risk frameworks to achieve sustainable enterprise performance improvement. This often involves detailed process mapping, KPI development, and embedding a culture of continuous improvement focused on quality and regulatory adherence.